Table 1. Patient demographics and clinical characteristics.
| Variables | Total | TXA | Control group | P value |
|---|---|---|---|---|
| Patients, N | 83 | 50 | 33 | – |
| Flaps, N | 98 | 63 | 35 | – |
| Age (years), mean (SD) | 51.1 (8.8) (N=83) | 51.4 (9.2) (N=50) | 50.6 (8.4) (N=33) | 0.679* |
| BMI (kg/m2), mean (SD) | 22.4 (3.1) (N=48) | 22.7 (3.0) (N=33) | 21.7 (3.2) (N=15) | 0.300* |
| Bilateral flaps, N (% patients) | 15 (18.1) | 13 (26.0) | 2 (6.1) | 0.022** |
| Current tobacco use, N (% patients) | 6 (7.2) | 5 (10.0) | 1 (3.0) | 0.395** |
| Diabetes, N | 0 | 0 | 0 | – |
| Neoadjuvant chemotherapy, N (% patients) | 8 (9.6) | 6 (12.0) | 2 (6.1) | 0.468** |
| Previous irradiation, N (% flaps) | 23 (23.5) | 14 (22.2) | 8 (22.9) | 1.000** |
*, Student’s t-test; **, Fisher test. TXA, tranexamic acid.